Literature DB >> 26254611

Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.

Hong Fan1,2, Zhujiang Zhao3,4, Yuchao Cheng3,4, He Cui3,4, Fengchang Qiao3,4, Ling Wang3,4, Jiaojiao Hu3,4, Huzhang Wu3,4, Wei Song3,4.   

Abstract

Aberrant DNA methylation of CpG site is among the earliest and most frequent alterations in developmental process and diseases including cancer. To elucidate the functional preferred site of DNMTs, we analyzed the feature of distinct methylated sequences and established the defined relationship between DNMTs and preference genomic DNA sequences. Small interfering RNA (siRNA) construct of DNTM1, DNMT3A, and DNMT3B was transfected into the human hepatocellular carcinoma cell line SMMC-7721, respectively. Distinguishing methylated fragments pool was enriched by SHH method in cells which is knocked down DNMT1, DNMT3A, DNMT3B, separately. The defined binding transcription factors (TFs) containing of 5'CpG islands were obtained with bioinformatics software and website. In SMMC-7721 hepatocellular carcinoma (HCC) cell line, DNMT1, DNMT3A, and DNMT3B were specific suppressed by their corresponding siRNA construct, separately. A 46, 42, 67 distinctive methylated fragments from three different DNMTs were evaluated according to genomic DNA database. Those separated fragments were distributed among genomic DNA regions of all chromosome complements, including coding genes, repeat sequences, and genes with unknown function. The majority of coding genes contain CpG islands in their promoter region. Cluster analysis demonstrated all of preference sequences identified by three DNMTs shares their own conserved sequences. In depleting of different DNMTs cells, 80 % of 103 upregulation genes induced by DNMT1 knock-down contain CpG sites; 76 % of 25 upregulation genes induced by DNMT3A knock-down contain CpG sites; 63 % of 126 upregulation genes induced by DNMT3B knock-down contain CpG sites. Our findings suggested that distinctive DNMTs targeted DNA methylation site to their preference sequences, and this targeting might be associated with diverse roles of DNMTs in tumorigenesis. Meanwhile, the analysis of preference sequences provides an alternative way to find out the individual function of DNMTs.

Entities:  

Keywords:  5′CpG site; DNA methyltranferases; Preference sequences

Mesh:

Substances:

Year:  2015        PMID: 26254611     DOI: 10.1007/s13277-015-3202-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  Genome-wide hypomethylation in hepatocellular carcinogenesis.

Authors:  C H Lin; S Y Hsieh; I S Sheen; W C Lee; T C Chen; W C Shyu; Y F Liaw
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 2.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 3.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

4.  CpG sites preferentially methylated by Dnmt3a in vivo.

Authors:  Masahiro Oka; Nemanja Rodić; Jamie Graddy; Lung-Ji Chang; Naohiro Terada
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

5.  Safeguarding parental identity: Dnmt1 maintains imprints during epigenetic reprogramming in early embryogenesis.

Authors:  Miguel R Branco; Masaaki Oda; Wolf Reik
Journal:  Genes Dev       Date:  2008-06-15       Impact factor: 11.361

Review 6.  DNA methylation errors and cancer.

Authors:  P A Jones
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

7.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

Review 8.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

9.  DNMT3L modulates significant and distinct flanking sequence preference for DNA methylation by DNMT3A and DNMT3B in vivo.

Authors:  Bethany L Wienholz; Michael S Kareta; Amir H Moarefi; Catherine A Gordon; Paul A Ginno; Frédéric Chédin
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

10.  Variations in DNA methylation during mouse cell differentiation in vivo and in vitro.

Authors:  A Razin; C Webb; M Szyf; J Yisraeli; A Rosenthal; T Naveh-Many; N Sciaky-Gallili; H Cedar
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more
  2 in total

1.  Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.

Authors:  Kun Liu; Yuening Zhang; Chengdong Zhang; Qinle Zhang; Jiatong Li; Feifan Xiao; Yingfang Li; Ruoheng Zhang; Dongwei Dou; Jiezhen Liang; Jian Qin; Zhidi Lin; Dong Zhao; Min Jiang; Zhenxin Liang; Jie Su; Vanaparthy Pranay Gupta; Min He; Xiaoli Yang
Journal:  Oncotarget       Date:  2016-08-30

Review 2.  DNMTs and Impact of CpG Content, Transcription Factors, Consensus Motifs, lncRNAs, and Histone Marks on DNA Methylation.

Authors:  Jaqueline Loaeza-Loaeza; Adriana S Beltran; Daniel Hernández-Sotelo
Journal:  Genes (Basel)       Date:  2020-11-12       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.